275 related articles for article (PubMed ID: 30584533)
21. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.
Clavé A; Gérard R; Lacroix J; Baynat C; Danguy des Déserts M; Gatineau F; Mottier D
Bone Joint J; 2019 Feb; 101-B(2):207-212. PubMed ID: 30700116
[TBL] [Abstract][Full Text] [Related]
22. The Michigan Experience with Safety and Effectiveness of Tranexamic Acid Use in Hip and Knee Arthroplasty.
Hallstrom B; Singal B; Cowen ME; Roberts KC; Hughes RE
J Bone Joint Surg Am; 2016 Oct; 98(19):1646-1655. PubMed ID: 27707851
[TBL] [Abstract][Full Text] [Related]
23. Intravenous tranexamic acid for reducing perioperative blood loss during revision hip arthroplasty: A retrospective study.
Wang Q; Yeersheng R; Li D; Yang Z; Kang P
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):519-523. PubMed ID: 33155563
[TBL] [Abstract][Full Text] [Related]
24. Oral tranexamic acid for an additional 24 hours postoperatively versus a single preoperative intravenous dose for reducing blood loss in total knee arthroplasty: results of a randomized controlled trial (TRAC-24).
Magill P; Hill JC; Bryce L; Martin U; Dorman A; Hogg R; Campbell C; Gardner E; McFarland M; Bell J; Benson G; Beverland D
Bone Joint J; 2021 Oct; 103-B(10):1595-1603. PubMed ID: 34587808
[TBL] [Abstract][Full Text] [Related]
25. A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty.
Mao Z; Yue B; Wang Y; Yan M; Dai K
BMC Musculoskelet Disord; 2016 Oct; 17(1):438. PubMed ID: 27760536
[TBL] [Abstract][Full Text] [Related]
26. Application of thromboelastography to evaluate the effect of different routes administration of tranexamic acid on coagulation function in total hip arthroplasty.
Xu X; Jiang J; Liu W; Li X; Lu H
J Orthop Surg Res; 2019 Dec; 14(1):430. PubMed ID: 31829245
[TBL] [Abstract][Full Text] [Related]
27. The optimal regimen of oral tranexamic acid administration for primary total knee/hip replacement: a meta-analysis and narrative review of a randomized controlled trial.
Ye W; Liu Y; Liu WF; Li XL; Shao J
J Orthop Surg Res; 2020 Oct; 15(1):457. PubMed ID: 33023637
[TBL] [Abstract][Full Text] [Related]
28. Early Discharge for Revision Total Knee and Hip Arthroplasty: Predictors of Success.
Albana MF; Yayac MF; Sun K; Post ZD; Ponzio DY; Ong AC
J Arthroplasty; 2024 May; 39(5):1298-1303. PubMed ID: 37972666
[TBL] [Abstract][Full Text] [Related]
29. The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical Trial.
Sershon RA; Fillingham YA; Abdel MP; Malkani AL; Schwarzkopf R; Padgett DE; Vail TP; Nam D; Nahhas C; Culvern C; Della Valle CJ;
J Bone Joint Surg Am; 2020 Nov; 102(21):1883-1890. PubMed ID: 33148955
[TBL] [Abstract][Full Text] [Related]
30. Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty.
Tille E; Mysliwietz J; Beyer F; Postler A; Lützner J
BMC Musculoskelet Disord; 2019 Jul; 20(1):341. PubMed ID: 31351459
[TBL] [Abstract][Full Text] [Related]
31. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
Lošťák J; Gallo J; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
[TBL] [Abstract][Full Text] [Related]
32. Unplanned Emergency Department Visits Following Revision Total Joint Arthroplasty: Incidences, Risk Factors, and Mortalities.
Lin YH; Hung TH; Chang CW; Chen YC; Tai TW
J Arthroplasty; 2024 Mar; 39(3):813-818.e1. PubMed ID: 37776981
[TBL] [Abstract][Full Text] [Related]
33. Low Risk of Thromboembolic Events After Routine Administration of Tranexamic Acid in Hip and Knee Arthroplasty.
Madsen RV; Nielsen CS; Kallemose T; Husted H; Troelsen A
J Arthroplasty; 2017 Apr; 32(4):1298-1303. PubMed ID: 27843042
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Preoperative Administration of Intravenous Tranexamic Acid During Revision Hip Arthroplasty: A Retrospective Study.
Peck J; Kepecs DM; Mei B; Safir OA; Backstein D; Gross AE; Kuzyk PR
J Bone Joint Surg Am; 2018 Sep; 100(17):1509-1516. PubMed ID: 30180060
[TBL] [Abstract][Full Text] [Related]
35. Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial.
Watts CD; Houdek MT; Sems SA; Cross WW; Pagnano MW
J Orthop Trauma; 2017 Jul; 31(7):345-351. PubMed ID: 28633147
[TBL] [Abstract][Full Text] [Related]
36. Efficiency of tranexamic acid in perioperative blood loss in hip arthroplasty: a systematic literature review and meta-analysis.
Pinzón-Florez CE; Vélez Cañas KM; Díaz Quijano DM
Rev Esp Anestesiol Reanim; 2015 May; 62(5):253-64. PubMed ID: 25542068
[TBL] [Abstract][Full Text] [Related]
37. Venous Thromboembolism Rates Did Not Decrease in Lower Extremity Revision Total Joint Arthroplasty From 2008 to 2016.
Warren JA; Sundaram K; Kamath AF; Molloy RM; Krebs VE; Mont MA; Piuzzi NS
J Arthroplasty; 2019 Nov; 34(11):2774-2779. PubMed ID: 31153709
[TBL] [Abstract][Full Text] [Related]
38. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Li JF; Li H; Zhao H; Wang J; Liu S; Song Y; Wu HF
J Orthop Surg Res; 2017 Feb; 12(1):22. PubMed ID: 28153031
[TBL] [Abstract][Full Text] [Related]
39. One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.
Wilde JM; Copp SN; McCauley JC; Bugbee WD
J Bone Joint Surg Am; 2018 Jul; 100(13):1104-1109. PubMed ID: 29975264
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of intravenous and intra-articular tranexamic acid on reducing hemoglobin loss in revision total knee arthroplasty: a prospective, randomized, controlled study.
Yuan X; Wang J; Wang Q; Zhang X
Transfusion; 2018 Apr; 58(4):982-988. PubMed ID: 29399799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
